Compare ZYME & ARCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZYME | ARCO |
|---|---|---|
| Founded | 2003 | 2007 |
| Country | United States | Uruguay |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.8B |
| IPO Year | 2022 | 2011 |
| Metric | ZYME | ARCO |
|---|---|---|
| Price | $23.40 | $7.66 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 2 |
| Target Price | ★ $38.90 | $8.60 |
| AVG Volume (30 Days) | 649.0K | ★ 1.2M |
| Earning Date | 03-02-2026 | 03-19-2026 |
| Dividend Yield | N/A | ★ 3.13% |
| EPS Growth | ★ 33.33 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $105,965,000.00 | N/A |
| Revenue This Year | $162.82 | $11.64 |
| Revenue Next Year | N/A | $6.59 |
| P/E Ratio | ★ N/A | $7.26 |
| Revenue Growth | ★ 38.87 | N/A |
| 52 Week Low | $9.03 | $6.51 |
| 52 Week High | $28.49 | $8.98 |
| Indicator | ZYME | ARCO |
|---|---|---|
| Relative Strength Index (RSI) | 47.53 | 36.17 |
| Support Level | $22.28 | $7.04 |
| Resistance Level | $23.66 | $7.73 |
| Average True Range (ATR) | 1.36 | 0.26 |
| MACD | -0.08 | -0.08 |
| Stochastic Oscillator | 16.70 | 15.00 |
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. It is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
Arcos Dorados Holdings Inc operates McDonald's branded restaurants in various countries and territories in Latin America and the Caribbean. The Company manages its business as distinct geographic segments and its operations are divided into three geographic divisions, as follows: Brazil, the North Latin American division, or NOLAD, which is comprised of Costa Rica, Mexico, Panama, Puerto Rico, Martinique, Guadeloupe, French Guiana and the U.S. Virgin Islands of St. Croix and St. Thomas and the South Latin American division, or SLAD, which is comprised of Argentina, Chile, Ecuador, Peru, Uruguay, Colombia, Venezuela, Trinidad and Tobago, Aruba and Curacao. Their menu includes hamburgers, McNuggets, salad, sandwiches, French fries, and others.